Free Trial
Earnings Season Is Here. MarketBeat All Access for Just $149
Get the Deal
Claim MarketBeat All Access Sale Promotion
NASDAQ:QDEL

QuidelOrtho Q3 2026 Earnings Date & Estimates

QuidelOrtho logo
$13.48 -0.60 (-4.26%)
Closing price 04:00 PM Eastern
Extended Trading
$13.48 0.00 (0.00%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

QuidelOrtho is estimated to report Q3 2026 earnings on Tuesday, November 3, 2026, after market closes. The conference call is scheduled for 5:00 PM ET.

Research:ProfileEarnings HistoryForecast

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
After Market Closes
Conference Call
5:00 PM ET
Google Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab)

What Analysts Expect from QuidelOrtho in Q3 2026

QuidelOrtho is expected to post earnings of $0.2023 per share on revenue of $627.83 million. In the same quarter a year earlier QuidelOrtho reported $0.80 per share on revenue of $699.90 million. QuidelOrtho last reported on August 6, 2026, posting $0.13 per share and beating the -$0.0488 consensus estimate. QuidelOrtho has beaten the consensus EPS estimate in 6 of its last 8 quarters.

Consensus Estimates

Consensus EPS
$0.2023
Expected Revenue
$627.83 million
Prior-Year EPS
$0.80
Prior-Year Revenue
$699.90 million
Expected EPS Growth
-74.7%
Expected Revenue Growth
-10.3%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
$0.13 (Beat by +$0.1788)
Last Quarter Revenue
$630.90 million
EPS Beat Rate
6 of last 8 quarters

Prepare for the Q3 2026 Call

QuidelOrtho Q3 2026 Earnings FAQ

QuidelOrtho (NASDAQ:QDEL) is estimated to report Q3 2026 earnings on Tuesday, November 3, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it.

QuidelOrtho's Q3 2026 earnings conference call is scheduled for Tuesday, November 3, 2026 at 5:00 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect QuidelOrtho to post earnings of $0.2023 per share for Q3 2026.

The consensus revenue estimate for QuidelOrtho is $627.83 million for Q3 2026.

QuidelOrtho Earnings Headlines

QuidelOrtho rebounds from recent weakness, jumps 12%
October 20 at 7:28 PM  |  seekingalpha.comhttps://seekingalpha.com/news/4654884-quidelortho-rebounds-from-recent-weakness-jumps-12
QuidelOrtho to Report Third Quarter 2026 Financial Results on November 3, 2026
October 20 at 8:00 AM  |  prnewswire.comhttps://www.prnewswire.com/news-releases/quidelortho-to-report-third-quarter-2026-financial-results-on-november-3-2026-302908607.html
You haven't downloaded this yet
Bill Poulos's Top 10 Stocks to Buy This Quarter report is still available free, but not for long. Every quarter he swaps in a brand-new list, and once the new edition launches, this one disappears. Investors who want a current snapshot of his picks should grab a copy now and save it before the switch happens.tc pixel
October 22 at 1:00 AM  |  Profits Run (Ad)
Analyzing LivaNova (NASDAQ:LIVN) and QuidelOrtho (NASDAQ:QDEL)
October 20 at 3:15 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31137893
QuidelOrtho (QDEL) Gets a Sell from J.P. Morgan
October 15, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/QDEL-Q/pressreleases/7822104/quidelortho-qdel-gets-a-sell-from-j-p-morgan/
QuidelOrtho Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 15, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/quidelortho-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-302910665.html
See More QuidelOrtho Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like QuidelOrtho? Sign up for Earnings360's daily newsletter to receive timely earnings updates on QuidelOrtho and other key companies, straight to your email.

About QuidelOrtho

QuidelOrtho (NASDAQ:QDEL) (NASDAQ:QDEL) is a global in vitro diagnostics company formed through the combination of Quidel Corporation and Ortho Clinical Diagnostics, a transaction completed in 2022. The company develops, manufactures and markets diagnostic technologies used to detect disease, guide treatment decisions and support blood-transfusion safety.

Its portfolio includes rapid immunoassays, molecular testing systems, clinical chemistry and immunohematology products, as well as laboratory automation solutions. Key product families include QuidelOrtho’s Sofia and QuickVue point-of-care testing platforms, Savanna molecular diagnostics system, and Ortho’s VITROS analyzers, ORTHO VISION blood-bank systems and related reagents and consumables.

QuidelOrtho serves hospitals, clinical laboratories, physician offices, urgent-care centers, pharmacies, blood banks and public-health organizations. The company operates across North America, Europe, Asia-Pacific and other international markets, providing diagnostic products for settings ranging from decentralized point-of-care testing to large automated laboratories. Its business combines Quidel’s expertise in rapid and molecular diagnostics with Ortho’s longstanding presence in laboratory and transfusion medicine.

View QuidelOrtho Profile
Earnings Tools